Target intelligence / Profile preview

Long intergenic non-protein coding RNA 882 (LINC00882)

Target
LINC00882
Molecular classification
Other (Long non-coding RNA), lncRNA
01

Overview

Long intergenic non-protein coding RNA 882 (LINC00882) is a long noncoding RNA (lncRNA) located on chromosome 3q13.12 that does not code for a protein but acts through RNA-mediated mechanisms[1][2]. LINC00882 is upregulated in several cancers, most notably hepatocellular carcinoma (HCC), where it promotes cell proliferation, migration, and invasion[1][2][4]. It exerts oncogenic functions partly by acting as a molecular sponge for microRNA miR-214-3p, thereby regulating downstream targets such as CENPM[1][2]. LINC00882 is primarily localized in the cytoplasm, consistent with its function as a competing endogenous RNA (ceRNA)[1][2]. High LINC00882 expression is associated with worse overall survival in HCC and may serve as a molecular biomarker for prognosis, but there are currently no known drugs directly targeting this RNA, and it is not classified as a canonical therapeutic target such as a receptor or enzyme[1][2][4].

Other names
LINC00882
02

Biological functions

Cell proliferationCell migrationCell invasionRegulation of gene expression (via miRNA sponging, e.g., miR-214-3p)Tumor progression
03

Disease associations

Cancer (notably hepatocellular carcinoma)Potential involvement in chromophobe renal cell carcinoma
04

Biomarkers

High expression in hepatocellular carcinoma (potential prognostic biomarker)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 882 (LINC00882).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 882 (LINC00882).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call